BAZ1B in Nucleus Accumbens Regulates Reward-Related Behaviors in Response to Distinct Emotional Stimuli by Sun, H. et al.
Neurobiology of Disease
BAZ1B in Nucleus Accumbens Regulates Reward-Related
Behaviors in Response to Distinct Emotional Stimuli
HaoSheng Sun,1 Jennifer A. Martin,2 XCraig T. Werner,2 Zi-JunWang,2Diane M. Damez-Werno,1 Kimberly N. Scobie,1
XNing-Yi Shao,1 Caroline Dias,1 Jacqui Rabkin,1 Ja Wook Koo,1 AmyM. Gancarz,2 XEzekiell A. Mouzon,1
Rachael L. Neve,3 Li Shen,1 XDavid M. Dietz,2 and XEric J. Nestler1
1Fishberg Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, 2Department of
Pharmacology and Toxicology and Institute on Addictions, The State University of New York at Buffalo, Buffalo, New York 14214, and 3Department of
Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139
ATP-dependent chromatin remodeling proteins are being implicated increasingly in the regulation of complex behaviors, including
models of several psychiatric disorders. Here, we demonstrate that Baz1b, an accessory subunit of the ISWI family of chromatin remod-
eling complexes, is upregulated in the nucleus accumbens (NAc), a key brain reward region, in both chronic cocaine-treated mice and
mice that are resilient to chronic social defeat stress. In contrast, no regulation is seen inmice that are susceptible to this chronic stress.
Viral-mediated overexpression of Baz1b, along with its associated subunit Smarca5, in mouse NAc is sufficient to potentiate both
rewarding responses to cocaine, including cocaine self-administration, and resilience to chronic social defeat stress. However, despite
these similar, proreward behavioral effects, genome-widemapping of BAZ1B in NAc revealedmostly distinct subsets of genes regulated
by these chromatin remodeling proteins after chronic exposure to either cocaine or social stress. Together, these findings suggest
important roles for BAZ1B and its associated chromatin remodeling complexes in NAc in the regulation of reward behaviors to distinct
emotional stimuli and highlight the stimulus-specific nature of the actions of these regulatory proteins.
Key words: Addiction; Baz1b; chromatin; depression; epigenetics; remodeler
Introduction
High comorbidity between depression and drug addiction sug-
gests a convergence of molecular mechanisms and neural cir-
cuitry in the regulation of reward-related and other emotional
behaviors (Ford et al., 2009; Russo and Nestler, 2013). Chronic
cocaine administration and chronic social defeat stress (CSDS)
each alter gene expression in the nucleus accumbens (NAc), an
important brain reward region, and chromatin regulation—in
particular, histone writers and erasers as well as proteins that
control DNAmethylation—has been shown to be important for
mediating these events (Renthal et al., 2007; Hunter et al., 2009;
Jiang et al., 2010; LaPlant et al., 2010;Maze et al., 2010; Covington
et al., 2011; Hollis et al., 2011; Sun et al., 2013; Deng et al., 2014;
Feng et al., 2015; Hodes et al., 2015). ATP-dependent chromatin
remodeling complexes also play a key role in regulating nucleo-
some positioning to control gene expression and have recently
been implicated in complex behavior such as learning and mem-
ory (Whitehouse et al., 2007; Clapier and Cairns, 2009; Yen et al.,
2012; Narlikar et al., 2013; Vogel-Ciernia et al., 2013). In addi-
tion, the persistent induction of BAZ1A, an accessory subunit of
the ISWI family of chromatin remodeling proteins, and the re-
sulting upregulation of the ACF complex in the NAc has been
shown to be important in mediating chronic-stress-induced
depressive-like behavior (Sun et al., 2015).
The related ISWI subunit, BAZ1B (also known as WSTF, or
Williams Syndrome Transcription Factor), was first discovered
bymapping the deletion region of patients with the developmen-
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Significance Statement
We show that BAZ1B, a component of chromatin remodeling complexes, in the nucleus accumbens regulates reward-related
behaviors in response to chronic exposure to both rewarding and aversive stimuli by regulating largely distinct subsets of genes.
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tal disorder Williams–Beuren syndrome (Lu et al., 1998; Peoples
et al., 1998). The BAZ family of proteins contain a BAZ type of
bromodomain (Jones et al., 2000) and BAZ1B in particular is
implicated in several chromatin remodeling/transcriptional
complexes (including associating with the ISWI subunit,
SMARCA5) with diverse roles in regulating DNA replication,
DNA repair, and transcription (Bozhenok et al., 2002; Poot et al.,
2004; Cavella´n et al., 2006; Percipalle et al., 2006; Xiao et al., 2009;
Vintermist et al., 2011; Culver-Cochran and Chadwick, 2013;
Lundqvist et al., 2013; Sarshad et al., 2013; Takada, 2015).
Here, we characterize the role of BAZ1B in NAc after chronic
exposure to two distinct emotional stimuli, cocaine and social
stress. We then map the binding of BAZ1B genome wide in this
brain region under both conditions to identify genomic regions
implicated in its behavioral actions.
Materials andMethods
Animals. C57BL/6J male mice (7–8 weeks old; Jackson Laboratory) were
housed at constant temperature (23°C) on a 12 h light/dark cycle with ad
libitum access to food and water. Experiments were initiated when the
animals were 9–10 weeks old. In CSDS experiments, CD1 retired male
breeder mice were used as aggressors (see below). Sprague Dawley male
rats (275–300 g; Harlan Laboratories) were used for cocaine self-
administration experiments. All protocols were approved by Mount Si-
nai’s Institutional Animal Care and Use Committee (IACUC) unless
specified otherwise.
Intraperitoneal cocaine administration. Cocaine hydrochloride (Sigma-
Aldrich) was dissolved in sterile 0.9% saline (w/v). Daily saline or cocaine
(20mg/kg, i.p.) injections were administered in the animals’ home cages.
NAcRNA isolation and qRT-PCR. Bilateral 14Ga punches ofNAcwere
obtained at varying times after the last cocaine or other treatment and
frozen on dry ice. Samples were then homogenized in TRIzol and pro-
cessed according to the manufacturer’s instructions. RNA was purified
with RNAeasy Micro columns and reverse transcribed using an iScript
Kit. cDNAwas quantified by qPCR using SYBR green. Each reaction was
performed in duplicate and analyzed following the standard Ct
method using Gapdh as a normalization control. Gapdh mRNA levels
were not affected by either cocaine or CSDS treatments.
Viral-mediated gene transfer. Herpes simplex virus (HSV) plasmids
were packaged into high-titer viral particles as described previously
(Maze et al., 2010). Viral titers were between 3 and 4 108 particles/ml.
Mice were positioned in small animal stereotaxic instruments under ket-
amine (100mg/kg)/xylazine (10 mg/kg) anesthesia and their cranial sur-
faces were exposed. Thirty-three gauge syringe needles were bilaterally
lowered into NAc (anterior/posterior1.6; medial/lateral1.5; dorsal/
ventral 4.4 mm from bregma, 10° angle) to infuse 0.5 l of virus.
Infusions occurred at a rate of 0.1 l/min. Animals receiving HSV injec-
tions were allowed to recover for at least 24 h after surgery.
Conditioned place preference (CPP). Place conditioning was performed
as described previously (Maze et al., 2010) with slight modifications.
Several visual and nonvisual (tactile) cues enabled the animals to distin-
guish two side chambers of a three-chamber apparatus. All conditioning
and test sessions were performed under dim illumination. Baseline pref-
erence wasmonitored and balanced 1 d before surgery. After surgery and
recovery, mice were conditioned for 30 min over 2 d to the saline-paired
side in the morning and the cocaine-paired side (7.5 mg/kg, i.p.) in the
afternoon. On the final day, mice were placed again in the central
compartment at noon and allowed to move freely between the two side
chambers for 20 min. CPP scores were calculated as time spent in the
cocaine-paired chamber minus the time spent in the saline-paired
chamber.
Locomotor activity. After recovery from surgery, mice were habituated
in a rectangular-shaped arena equipped with motion sensors for 1 d for
30min and thenmonitored for locomotor activity after a saline injection
(LaPlant et al., 2010; Scobie et al., 2014). Cocaine (10 mg/kg. i.p.) was
then administered daily in the locomotor box for 5 d, with locomotor
activity monitored for 30 min thereafter.
Cocaine self-administration. This study was conducted in accordance
with the guidelines set up by the IACUC of the State University of New
York at Buffalo. The details of this procedure have been described previ-
ously (Scobie et al., 2014; Gancarz et al., 2015). Briefly, naive male
Sprague Dawley rats were implanted with jugular catheters, allowed 7 d
of recovery, after which they were randomly assigned to self-administer
either saline or cocaine (1 mg/kg/infusion). Rats were tested for self-
administration for 10 daily 2 h sessions, during which responses at the
active snout-poke hole resulted in intravenous injections of cocaine (or
saline) according to a fixed ratio 1 schedule. Infusions were accompanied
by a 5 s illumination of the stimulus light above the active snout-poke
hole. Responses at the inactive snout-poke hole resulted in no pro-
grammed consequences. After the last day of self-administration, the rats
were returned to their colony rooms and left undisturbed for 7 d. They
were subsequently retested for a single-self-administration session in an
identical manner as in previous self-administration sessions and killed
24 h after the reexposure test for tissue collection.
For the cocaine dose–response experiment, a separate cohort of rats
were first exposed to 5 d of cocaine self-administration, during which
animals underwent self-administration training as described above. On
day 6, animals were subsequently trained on a within-session dose–
response procedure for 5 additional days (Scobie et al., 2014; Gancarz et
al., 2015). Briefly, the self-administration period was divided into 5 30
min components, each preceded by a 2 min timeout period. This ar-
rangement allowed the assessment of a range of cocaine doses in a single
session. The cocaine dose per injection was regulated by adjusting infu-
sion volumes and pump durations. Rats were exposed to 5 doses of
cocaine (0.03, 0.06, 0.10, 0.30, and 1.00 mg/kg/infusion) for 30 min. The
order of doses tested was pseudorandomized such that the same doses
were never tested in the same order during training. After training, ani-
mals were counterbalanced according to self-administration perfor-
mance and infused with either HSV-GFP or HSV-BAZ1B SMARCA5
in the NAc. After recovery from stereotaxic surgeries, animals were
placed in the operant chambers and retested on the within-session dose–
response procedure described above. In addition, animals were tested in
a paradigm that is thought to be an indirect measure of drug seeking (Li
et al., 2015; Werner et al., 2015). Briefly, animals were placed back in the
operant chambers with all of the same cues, but without drug infusions,
and responses in the previously active snout-poke hole were measured
for 1 h.
Western blotting. Frozen NAc tissue was homogenized in 30 l of
buffer containing 10mMTris, 150mMNaCl, 1mM EDTA, 0.1% SDS, 1%
Triton X-100, 1% sodiumdeoxycholate, and protease inhibitors (Roche)
using an ultrasonic processor (Cole Parmer). Protein concentrations
were determined using a DC protein assay (Bio-Rad) and 50 g of pro-
tein was loaded onto 4–15% gradient Tris-HCl polyacrylamide gels for
electrophoresis fractionation (Bio-Rad). Proteins were transferred to ni-
trocellulose membranes, blocked with Odyssey blocking buffer (Li-Cor)
and incubated overnight at 4°Cwith primary antibodies (BAZ1B: Abcam
ab51256, 1/500; SMARCA5: Abcam ab3749, 1/500) in Odyssey blocking
buffer. After thorough washing with 1 Tris-buffered saline plus 0.1%
Tween 20, membranes were incubated with IRDye secondary antibodies
(1/5000 to 1/10000; Li-Cor) dissolved in Odyssey blocking buffer for 1 h
at room temperature. For analysis, the blots were imaged with the Odys-
sey Infrared Imaging system (Li-Cor) and quantified by densitometry
using ImageJ. The amount of protein blotted onto each lane was normal-
ized to levels of GAPDH (Cell Signaling Technology 2118, 1/30000) or
-actin (Cell Signaling Technology 3700, 1/10000), the levels of which
were not affected by cocaine or CSDS treatments.
CSDS. CSDSwas performed exactly as described previously (Berton et
al., 2006; Krishnan et al., 2007). Briefly, an experimental C57BL/6J
mouse was placed into the home cage of a CD1mouse for 10min, during
which time it was physically defeated by the CD1 mouse. After the phys-
ical interaction, the CD1 and experimental mouse were maintained in
sensory contact for 24 h using a perforated Plexiglas partition dividing
the resident home cage in two. The experimental mice were exposed to a
new CD1 mouse for 10 consecutive days. Other than not being exposed
to physical defeat by a CD1 mouse, control mice were housed under
similar conditions as CSDS mice with a perforated Plexiglas separating
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two controlmice. The controlmicewere also handled daily like theCSDS
mice so that they were exposed to a novel control mouse for 10 consec-
utive days. A social interaction (SI) test was performed 24 h after the last
defeat or control session on both CSDS and control mice (Berton et al.,
2006). For the SI test, mice were placed in an open field that included an
interaction zone and two opposing corner zones. A social target (novel
CD1 mouse) was placed in a metal meshplastic box in the interaction
zone, which allows sensory but not physical interaction. Ethovision XT
(Noldus) tracking software was used to measure the time that the test
mouse spent in the interaction zone with and without the target CD1
present (2.5 min). The SI ratio was calculated as follows: (time in inter-
action zone with target CD1)/(time in interaction zone without CD1)
100. CSDS mice with an SI ratio of100 were categorized as susceptible
and those with SI ratios of 100 and above were termed resilient. This
determination has been shown to be a highly reliable measure of two
distinct phenotypic responses to CSDS and has been validated in numer-
ous studies (Krishnan et al., 2007; LaPlant et al., 2010; Sun et al., 2015).
ChIP, library preparation, and sequencing. ChIP, library preparation,
and sequencing were performed as described previously (Feng et al.,
2014; Sun et al., 2015). For each ChIP-sequencing (ChIP-seq) replicate,
bilateral 14GaNAcpuncheswere pooled from five to 10mice. Tissuewas
lightly fixed to cross-link DNA with associated proteins and the material
was further sheared using a Bioruptor to obtain mostly 100–300 bp
fragments and immunoprecipitated using sheep anti-rabbit magnetic
beads conjugated to an antibody that specifically recognizes BAZ1B. Im-
munoprecipitated DNA and total (input) genomic DNA were prepared
for ChIP-seq using an Illumina kit according to the manufacturer’s in-
structions. Each experimental condition was analyzed with independent
biological triplicates. Amplification and size selection were confirmed
with a BioAnalyzer. The resulting libraries were sequenced on an Illu-
mina HiSeq 2500 with 100 bp read length.
ChIP-seq data analysis. ChIP-seq data were aligned to the mouse
genome (mm9) by CASAVA 1.8, and only unique reads were retained
for analysis. FastQC (http://www.bioinformatics.babraham.ac.uk/
projects/fastqc/) was applied for quality control and then SAMTools
(http://samtools.sourceforge.net) was used to remove potential PCR
duplicates (Li et al., 2009). PhantomPeak (https://code.google.com/p/
phantompeakqualtools/) was applied to estimate the quality and enrich-
ment of the ChIP-seq dataset (Landt et al., 2012). Additional ENCODE
quality metrics, such as the normalized strand coefficient (NSC) and the
relative strand correlation (RSC), were calculated. For all samples in our
research, NSC was1.05 and RSC was0.8. Basic filtering and quality
control confirmed that these sampleswere of strong quality and exceeded
ENCODE standards (Landt et al., 2012). Differential analysis between
treatment groups was performed with an in-house program called
diffReps. For more details, please refer to http://code.google.com/p/
diffreps/ (Shen et al., 2013). The Corrgram package in R software was
used to calculate and visualize the correlation between different chroma-
tin remodelers and histone marks. TDF files (all duplicative/redundant
reads 2 removed) were applied in IGV for genome browser views of
ChIP-seq tracks.
Statistical analysis. Student’s t tests were used whenever two groups
were compared. One-way and two-way ANOVAs were performed wher-
ever necessary to determine significance for all other data. Significant
main effects (p 0.05) were further analyzed using post hoc tests.
Results
BAZ1B and SMARCA5 in cocaine action
We first assessed the effect of chronic administration of cocaine
on expression levels of Baz1b (an accessory ISWI subunit) and
Smarca5 (a core ISWI ATPase subunit) in the NAc. We found
that mRNA levels of both Baz1b (t(12) 3.309, p 0.0062) and
Smarca5 (t(12) 3.537, p 0.0041) were transiently but signifi-
cantly increased 30min after 7 daily cocaine injections (20mg/kg,
i.p.) compared with saline controls (Fig. 1A). This increase re-
turned to control levels 24 h and 7 d after the last injection (Fig.
1A). A similar induction of NAc BAZ1B mRNA (t(11)  2.798,
p  0.017) and protein levels (t(18)  2.456, p  0.024) was
observed after chronic cocaine self-administration (Fig.
1B,C), whereas a nonstatistically significant trend for an in-
crease in Smarca5 mRNA levels was observed after cocaine self-
administration (t(11) 1.694, p 0.118).
To examine directlywhether increasedBaz1b levels inNAc are
causally important in regulating cocaine reward behavior, we
used HSV-mediated gene transfer to rapidly overexpress BAZ1B
(t(9) 2.584, p 0.030) and SMARCA5 (t(13) 2.413, p 0.031)
in this brain region (Fig. 1D). In an unbiased cocaine CPP para-
digm, which provides an indirect measure of drug reward, ani-
mals with BAZ1B overexpression alone in NAc did not differ in
cocaine preference compared with HSV-GFP controls (Fig. 1E;
one-way ANOVA: F(2,28)  3.578, p  0.0413; GFP vs BAZ1B:
Dunnett’s post hoc, q 1.580, p 0.05). In contrast, animals with
cooverexpression in NAc of BAZ1B plus SMARCA5 showed a
significant increase in cocaine preference (Fig. 1E; Dunnett’s post
hoc, q  2.526, p  0.05). Overexpression of SMARCA5 alone
had no effect (data not shown). These observations are consistent
with the knowledge, derived from cultured cells, that BAZ1B and
SMARCA5 together form a functional complex that regulates
nucleosome positioning (see Discussion). Similarly, BAZ1B 
SMARCA5 overexpression in NAc increased locomotor re-
sponses to repeated cocaine exposures compared with HSV-GFP
controls, whereas it did not affect locomotor behavior in re-
sponse to saline injections (Fig. 1F, two-way ANOVA: group
F(3,84)  19.13, p  0.0001; day F(5,84)  3.623, p  0.0051;
interaction F(15,84) 1.465, NS).
Next, we investigated whether BAZ1B and SMARCA5 over-
expression in NAc affected cocaine self-administration. Using a
within-session dose–response self-administration procedure, we
found that overexpression of BAZ1B and SMARCA5 in NAc in-
creased cocaine self-administration (Fig. 1G, 2-way ANOVA:
dose F(4,48) 17.80, p 0.0001; interaction F(4,48) 2.658, p
0.044), particularly at the lower doses (0.03 mg/kg: t(12) 2.127,
p  0.0549; 0.06 mg/kg: t(12)  3.826, p  0.0024). In addition,
after withdrawal, animals with BAZ1B SMARCA5 overexpres-
sion in NAc exhibited increased drug-seeking behavior com-
pared with GFP control animals when placed back in the operant
chamberswith all of the same cues but nodrug infusions (Fig. 1H,
t(12) 2.216, p 0.0467). Together, these lines of evidence sug-
gest that the BAZ1B-SMARCA5 complex increases sensitivity
to cocaine reward.
BAZ1B and SMARCA5 in CSDS
We next examined the regulation of Baz1b in NAc by CSDS, an
ethologically validated mouse model of depression (Berton et al.,
2006; Krishnan et al., 2007; Hollis et al., 2011). Over 10 consecu-
tive days, C57BL/6J male mice were subjected to daily 10 min
aggressive encounters with CD1 mice, followed by sensory but
not physical contact for the remainder of the day. After CSDS,
	65% of test mice exhibited depression-related behavioral
abnormalities including social avoidance and were termed sus-
ceptible, whereas the remaining	35% did not exhibit these be-
havioral abnormalities andwere termed resilient (Krishnan et al.,
2007; Fig. 2A). Baz1b mRNA levels in NAc of resilient animals
were elevated 48 h after the last CSDS session compared with
nonstressed controls (Fig. 2B; one-way ANOVA: F(2,47) 10.80,
p 0.0001; control vs resilient: Dunnett’s post hoc q 4.540, p
0.001), with no differences observed 10 d after CSDS (Fig. 2C;
One-way ANOVA: F(2,20)  3.441, p  0.0543; control vs resil-
ient: Dunnett’s post hoc q  2.153, p  0.05). BAZ1B protein
levels were similarly increased in resilient animals 48 h afterCSDS
(Fig. 2D; one-wayANOVA: F(2,18) 3.394, p 0.0591; control vs
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resilient: Dunnett’s post hoc q 2.536, p 0.05). No differences
were observed for NAc BAZ1B mRNA and protein levels in sus-
ceptible animals nor for NAc SMARCA5 mRNA and protein
levels in susceptible or resilient animals compared with controls
(Fig. 2B–D).
To test directly the hypothesis that elevated BAZ1B levels play
a causal role in regulating resilience to social stress, we overex-
pressed BAZ1B plus SMARCA5 selectively in NAc of adult ani-
mals and then examined stress susceptibility versus resilience
using an accelerated repeated social defeat protocol that induces
behavioral deficits in HSV-GFP control mice within the time
frame of maximal HSV-mediated transgene expression (Krish-
nan et al., 2007; Sun et al., 2015). Animals overexpressing BAZ1B
SMARCA5 inNAc showed increased social interaction compared
with HSV-GFP controls (Fig. 2E; t(12)  3.614, p  0.0036.),
indicating that induction of NAc BAZ1B increases resilience to
social defeat stress.
Genome-wide mapping of BAZ1B binding in NAc under
cocaine and CSDS conditions
We used ChIP-seq to map BAZ1B binding genome wide in NAc
under control, cocaine, and CSDS conditions. Using diffreps
(Shen et al., 2013), we determined sites of differential BAZ1B
binding between saline- and cocaine-treated animals, as well as
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Figure1. BAZ1B inNAc in cocaine action.A,Baz1b and Smarca5mRNA levels inNAc 30min, 24h, and7d after 7 daily intraperitoneal injections of 20mg/kg cocaine or saline (0.9%w/v).B,Baz1b
and Smarca5mRNA levels in NAc 24 h after cocaine self-administration. C, BAZ1B protein levels in NAc 24 h after cocaine self-administration.D, Validation of HSV viral overexpression of BAZ1B and
SMARCA5 in mouse NAc. E, BAZ1B SMARCA5 overexpression in NAc enhances cocaine reward as measured by CPP. F, BAZ1B SMARCA5 overexpression in NAc enhances cocaine-induced
locomotor activity. G, BAZ1B SMARCA5 overexpression in NAc enhances cocaine self-administration at lower doses. H, BAZ1B SMARCA5 overexpression in NAc enhances cue-induced drug
seeking. For A, B, E, F, experimental paradigms are shown above each panel. #0.05 p 0.10, *p 0.05, **p 0.01 in respective comparisons.
Sun et al. • NAc BAZ1B Regulates Reward-Related Behaviors J. Neurosci., April 6, 2016 • 36(14):3954–3961 • 3957
between control, susceptible, and resilient animals. There were
223 increased BAZ1B binding events (at 78 genic and 145 inter-
genic sites) after chronic cocaine compared with saline and 159
decreased BAZ1B-binding events (at 52 genic and 107 intergenic
sites) (Fig. 3A; genic: 2(df 1) 5.200, p 0.0113; intergenic:
2(df  1)  5.730, p  0.0084). This is consistent with our
observation of BAZ1B induction in NAc after cocaine exposure
(Fig. 1A–C). Likewise, we observed increased genome-wide bind-
ing of BAZ1B in NAc of resilient animals compared with control
mice (167 increased and 75 decreased) and susceptible mice (115
increased and 61 decreased) (Fig. 3B,C). The increased genome-
wide BAZ1B binding in resilient animals was observed in both
genic and intergenic regions (resilient vs control: genic: 2(df
1) 34.975, p 0.0001; intergenic: 2(df 1) 173.376, p
0.0001; resilient vs susceptible: genic: 2(df  1)  16.568, p 
0.0001; intergenic: 2(df 1) 29.823, p 0.0001).
Wenext investigatedwhether the upregulated BAZ1Bbinding
in NAc of cocaine-exposed mice and of resilient mice after CSDS
occur at similar or distinct subsets of genes. Of the 162 and 69
genes that showed increased NAc BAZ1B binding in cocaine-
treated and resilient animals, respectively, there was only overlap
of 4 genes (221040812Rik, Anks1b, Col19a1, and Sphkap), sug-
gesting that BAZ1Bpromotes cocaine reward and stress resilience
mainly by regulating different subsets of genes (Fig. 3D, top).
Similarly, decreased BAZ1B binding in cocaine-treated and resil-
ient animals occurred in a distinct subset of genes with minimal
overlap (Fig. 3D, bottom). We examined one of the four genes
that showed increased BAZ1B binding in NAc under both co-
caine and resilient conditions, Sphkap (sphingosine kinase type
1-interacting protein), and confirmed increased BAZ1B binding
in both conditions relative to their respective controls (Fig. 3E).
Interestingly, at these sites that showed increased BAZ1B bind-
ing, there was no obvious increase in SMARCA5 binding, but
rather subtle shifting of SMARCA5 location within these regions
(Fig. 3E).
To examine BAZ1B’s potential transcriptional role, we corre-
lated BAZ1B binding in promoter regions genome-wide with
publishedChIP-seq data for SMARCA5 and for several well stud-
ied histone marks (Feng et al., 2014; Feng et al., 2015; Sun et al.,
2015; Fig. 3F). There was a strong positive correlation between
BAZ1B and SMARCA5 binding (r  0.873), suggesting that
BAZ1B is at least partly working with SMARCA5 to exert its
regulation. Agreeing with the previously reported transcription-
ally activating role of BAZ1B in other systems (Vintermist et al.,
2011; Culver-Cochran and Chadwick, 2013; Lundqvist et al.,
2013; Sarshad et al., 2013; Takada, 2015), we found positive cor-
relations between BAZ1B binding and three activating histone
marks, H3K4me3 (r  0.117), H3K4me1 (r  0.279), and
H3K27Ac (r 0.332), and a negative correlation betweenBAZ1B
and two repressive marks, H3K9me2 (r  0.165) and
H3K9me3 (r  0.101). Surprisingly, BAZ1B had a significant
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positive correlation with the repressive mark H3K27me3 (r 
0.168).
Discussion
Results from the present study demonstrate that BAZ1B is up-
regulated in NAc by two types of chronic emotional stimuli, co-
caine and social defeat stress. Our functional experiments
indicate that induction of BAZ1B in NAc enhanced behavioral
responses to cocaine both for noncontingent (CPP and loco-
motor activity) and contingent (self-administration and drug-
seeking/relapse) paradigms, whereas such induction enhanced
resilience to chronic stress. Together, these data establish that
BAZ1B inNAc regulates behavioral responses to emotional stim-
uli: elevated levels of BAZ1B in this brain region heighten re-
sponses to rewarding stimuli and promote adaptive responses to
aversive stimuli. Interestingly, the upregulation of BAZ1B by
either stimulus does not persist for the duration of behavioral
effects elicited by these two stimuli: Baz1b levels return to control
values within hours or days of cocaine or stress exposure despite
the fact that the behavioral sequelae of these treatments persist for
weeks or months. In addition, Baz1b upregulation caused by
chronic cocaine is more transient (minutes to hours after intra-
peritoneal cocaine) compared with that caused by CSDS (days),
an observation that was also reported for another chromatin reg-
ulator, Dmnt3a (LaPlant et al., 2010).
The transient nature of these regulation events suggests that
BAZ1B may control other genes to exert longer-term behavioral
effects. Our ChIP-seq data demonstrate altered binding of
BAZ1B at numerous target genes after either stimulus. However,
these genome-wide data show that these distinct emotional stim-
uli regulate virtually nonoverlapping subsets of genes to exert
their functional effects. This is a surprising finding because, in
both conditions (cocaine and CSDS), BAZ1B induction in NAc
can be seen as enhancing reward. Our data thus underscore the
important principle that an individual chromatin regulatory pro-
tein acting in the same tissue can exert very different molecular
actions based on the larger context of the stimulus. The very small
number of genes (e.g., Sphkap) that exhibited similar BAZ1B
regulation after both chronic cocaine and CSDS may be molecu-
lar candidates in NAc that control global emotional states in
response to rewarding or aversive stimuli, whereas the largely
distinct subsets may represent those necessary in response to
specific stimuli. Sphkap encodes an interesting protein that is
thought to link cAMP and sphingosine signaling pathways
(Kovanich et al., 2010). The ChIP-seq data reported here there-
fore provide new avenues for understanding the biologicalmech-
anisms in NAc that control cocaine reward and stress resilience.
An important question to address in the future is how the same
complex (BAZ1B-SMARCA5) can regulate distinct subsets of
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genes in response to different stimuli (e.g., whether distinct co-
factors are recruited, etc.).
We recently implicated a related gene, Baz1a, in NAc in me-
diating susceptibility to CSDS (Sun et al., 2015), whereas here, we
demonstrate an opposite role for Baz1b in promoting stress resil-
ience. This suggests that closely related ISWI subunits can form
different chromatin remodeling complexes with very distinct
functional consequences. Although controversy remains con-
cerning the exact complexes thatBaz1b forms in different systems
(Yoshimura et al., 2014), our overexpression studies as well as the
high level of coincidence of BAZ1B binding with SMARCA5
binding genome-wide inNAc suggest that BAZ1B exerts its effect
at least partly through association with SMARCA5. Likewise,
BAZ1A is also thought to work in large part by complexing with
SMARCA5 (see Sun et al., 2015). An interesting parallel between
Baz1a and Baz1b is that whereas only the accessory subunit (i.e.,
Baz1a orBaz1b) is regulated byCSDSwithout coregulation of the
active ATPase (i.e., Smarca5), viral overexpression typically re-
quires both components to exert a behavioral effect. However,
whereas increased BAZ1A binding at genomic regions is typically
associated with increased SMARCA5 binding (Sun et al., 2015),
this does not seem to be true for the BAZ1B-SMARCA5 complex,
at least at the Sphkap locus, for example (Fig. 3E). Rather, in-
creased BAZ1B binding after chronic cocaine or CSDS seems to
redistribute subtly the binding of SMARCA5 around the affected
locus rather than increasing its binding levels. Whether these
differences contribute to different downstream effects remain
interesting biochemical and mechanistic questions to address
about these complexes in the future.
Consistentwith previously reported transcriptional activation
roles of BAZ1B in cell culture systems, we show here that BAZ1B
binding at gene promoters in NAc is positively correlated with
several histone marks associated with transcriptional activation
(H3K4me3, H3K4me1, and H3K27Ac) and negatively correlated
with histone marks associated with transcriptional repression
(H3K9me3 and H3K9me2). However, it is curious that BAZ1B
binding is also positively correlated with the repressive
H3K27me3 mark. This novel finding suggests that BAZ1B may
contribute to the regulation of genes with bivalent chromatin
domains that have been implicated in poising certain genes for
especially dynamic regulation (Watson et al., 2012). Whether
BAZ1B contributes to the regulation of such bivalent chromatin
domains in NAc or other brain regions is a worthy subject for
future investigation.
Together, results of the present study establish that induction
of Baz1b in NAc both promotes cocaine reward behavior and
promotes resilience to chronic social stress, indicating that it is
important for the regulation of reward and other emotional
behaviors. These findings will guide future investigations
aimed at better understanding the biological basis of cocaine-
and stress-related disorders, a prerequisite for devising more
effective treatments.
References
Berton O, McClung CA, Dileone RJ, Krishnan V, Renthal W, Russo SJ, Gra-
ham D, Tsankova NM, Bolanos CA, Rios M, Monteggia LM, Self DW,
Nestler EJ (2006) Essential role of BDNF in the mesolimbic dopamine
pathway in social defeat stress. Science 311:864–868. CrossRef Medline
Bozhenok L, Wade PA, Varga-Weisz P (2002) WSTF-ISWI chromatin re-
modeling complex targets heterochromatic replication foci. EMBO J 21:
2231–2241. CrossRef Medline
Cavella´n E, AspP, Percipalle P, Farrants AK (2006) TheWSTF-SNF2h chro-
matin remodeling complex interacts with several nuclear proteins in tran-
scription. J Biol Chem 281:16264–16271. CrossRef Medline
Clapier CR, Cairns BR (2009) The biology of chromatin remodeling com-
plexes. Annu Rev Biochem 78:273–304. CrossRef Medline
Covington HE 3rd, Maze I, Sun H, Bomze HM, DeMaio KD, Wu EY, Dietz
DM, Lobo MK, Ghose S, Mouzon E, Neve RL, Tamminga CA, Nestler EJ
(2011) A role for repressive histonemethylation in cocaine-induced vul-
nerability to stress. Neuron 71:656–670. CrossRef Medline
Culver-Cochran AE, Chadwick BP (2013) Loss of WSTF results in sponta-
neous fluctuations of heterochromatin formation and resolution, com-
bined with substantial changes to gene expression. BMC Genomics 14:
740. CrossRef Medline
Deng JV, Wan Y, Wang X, Cohen S, Wetsel WC, Greenberg ME, Kenny
PJ, Calakos N, West AE (2014) MeCP2 phosphorylation limits
psychostimulant-induced behavioral and neuronal plasticity. J Neurosci
34:4519–4527. CrossRef Medline
Feng J,WilkinsonM, Liu X, Purushothaman I, FergusonD, Vialou V,Maze I,
Shao N, Kennedy P, Koo J, Dias C, Laitman B, Stockman V, LaPlant Q,
Cahill ME, Nestler EJ, Shen L (2014) Chronic cocaine-regulated epig-
enomic changes in mouse nucleus accumbens. Genome Biol 15:R65.
CrossRef Medline
Feng J, ShaoN, Szulwach KE, Vialou V, Huynh J, Zhong C, Le T, FergusonD,
Cahill ME, Li Y, Koo JW, Ribeiro E, Labonte B, Laitman BM, Estey D,
StockmanV, Kennedy P, Courousse T,Mensah I, Turecki G, et al. (2015)
Role of Tet1 and 5-hydroxymethylcytosine in cocaine action. Nat Neuro-
sci 18:536–544. CrossRef Medline
Ford JD, Gelernter J, DeVoe JS, Zhang W, Weiss RD, Brady K, Farrer L,
Kranzler HR (2009) Association of psychiatric and substance use dis-
order comorbidity with cocaine dependence severity and treatment
utilization in cocaine-dependent individuals. Drug Alcohol Depend
99:193–203. CrossRef Medline
Gancarz AM,Wang ZJ, Schroeder GL, Damez-Werno D, Braunscheidel KM,
Mueller LE, Humby MS, Caccamise A, Martin JA, Dietz KC, Neve RL,
Dietz DM (2015) Activin receptor signaling regulates cocaine-primed
behavioral and morphological plasticity. Nat Neurosci 18:959–961.
CrossRef Medline
Hodes GE, Pfau ML, Purushothaman I, Ahn HF, Golden SA, Christoffel DJ,
Magida J, Brancato A, Takahashi A, FlaniganME, Menard C, Aleyasin H,
Koo JW, Lorsch ZS, Feng J, Heshmati M, Wang M, Turecki G, Neve R,
Zhang B, et al. (2015) Sex differences in nucleus accumbens transcrip-
tomeprofiles associatedwith susceptibility versus resilience to subchronic
variable stress. J Neurosci 35:16362–16376. CrossRef Medline
Hollis F, Duclot F, Gunjan A, KabbajM (2011) Individual differences in the
effect of social defeat on anhedonia and histone acetylation in the rat
hippocampus. Horm Behav 59:331–337. CrossRef Medline
Hunter RG, McCarthy KJ, Milne TA, Pfaff DW, McEwen BS (2009) Regu-
lation of hippocampal H3 histone methylation by acute and chronic
stress. Proc Natl Acad Sci U S A 106:20912–20917. CrossRef Medline
Jiang Y, Jakovcevski M, Bharadwaj R, Connor C, Schroeder FA, Lin CL,
Straubhaar J, Martin G, Akbarian S (2010) Setdb1 histone methyltrans-
ferase regulates mood-related behaviors and expression of the NMDA
receptor subunit NR2B. J Neurosci 30:7152–7167. CrossRef Medline
Jones MH, Hamana N, Nezu Ji, Shimane M (2000) A novel family of bro-
modomain genes. Genomics 63:40–45. CrossRef Medline
Kovanich D, van der HeydenMA, Aye TT, van Veen TA, Heck AJ, Scholten A
(2010) Sphingosine kinase interacting protein is an A-kinase anchoring
protein specific for type I cAMP-dependent protein kinase. Chembi-
ochem 11:963–971. CrossRef Medline
Krishnan V, Han MH, Graham DL, Berton O, Renthal W, Russo SJ, Laplant
Q,GrahamA, LutterM, LagaceDC,Ghose S, Reister R, Tannous P, Green
TA, Neve RL, Chakravarty S, Kumar A, Eisch AJ, Self DW, Lee FS, et al.
(2007) Molecular adaptations underlying susceptibility and resistance to
social defeat in brain reward regions. Cell 131:391–404. CrossRefMedline
Landt SG, Marinov GK, Kundaje A, Kheradpour P, Pauli F, Batzoglou S,
Bernstein BE, Bickel P, Brown JB, Cayting P, Chen Y, DeSalvo G, Epstein
C, Fisher-Aylor KI, Euskirchen G, Gerstein M, Gertz J, Hartemink AJ,
Hoffman MM, Iyer VR, et al. (2012) ChIP-seq guidelines and practices
of the ENCODE and modENCODE consortia. Genome Res 22:1813–
1831. CrossRef Medline
LaPlant Q, Vialou V, Covington HE 3rd, Dumitriu D, Feng J, Warren BL,
Maze I, Dietz DM,Watts EL, Iniguez SD, Koo JW,Mouzon E, RenthalW,
Hollis F, Wang H, Noonan MA, Ren Y, Eisch AJ, Bolanos CA, Kabbaj M,
et al. (2010) Dnmt3a regulates emotional behavior and spine plasticity
in the nucleus accumbens.NatNeurosci 13:1137–1143. CrossRefMedline
3960 • J. Neurosci., April 6, 2016 • 36(14):3954–3961 Sun et al. • NAc BAZ1B Regulates Reward-Related Behaviors
Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G,
Abecasis G, Durbin R; 1000 Genome Project Data Processing Subgroup
(2009) The Sequence Alignment/Map format and SAMtools. Bioinfor-
matics 25:2078–2079. CrossRef Medline
Li X, Rubio FJ, Zeric T, Bossert JM, Kambhampati S, Cates HM, Kennedy PJ,
LiuQR,CimbroR,HopeBT,Nestler EJ, ShahamY (2015) Incubation of
methamphetamine craving is associatedwith selective increases in expres-
sion of Bdnf and trkb, glutamate receptors, and epigenetic enzymes in
cue-activated fos-expressing dorsal striatal neurons. J Neurosci 35:8232–
8244. CrossRef Medline
Lu X,Meng X,Morris CA, KeatingMT (1998) A novel human gene,WSTF,
is deleted inWilliams syndrome. Genomics 54:241–249. CrossRefMedline
Lundqvist J, Hansen SK, Lykkesfeldt AE (2013) Vitamin D analog EB1089
inhibits aromatase expression by dissociation of comodulator WSTF
from the CYP19A1 promoter-a new regulatory pathway for aromatase.
Biochim Biophys Acta 1833:40–47. CrossRef Medline
Maze I, Covington HE 3rd, Dietz DM, LaPlant Q, Renthal W, Russo SJ,
MechanicM,MouzonE,NeveRL,Haggarty SJ, RenY, Sampath SC,Hurd
YL, Greengard P, TarakhovskyA, Schaefer A,Nestler EJ (2010) Essential
role of the histone methyltransferase G9a in cocaine-induced plasticity.
Science 327:213–216. CrossRef Medline
Narlikar GJ, Sundaramoorthy R, Owen-Hughes T (2013) Mechanisms and
functions of ATP-dependent chromatin-remodeling enzymes. Cell 154:
490–503. CrossRef Medline
Peoples RJ, CiscoMJ, Kaplan P, Francke U (1998) Identification of theWB-
SCR9 gene, encoding a novel transcriptional regulator, in the Williams-
Beuren syndrome deletion at 7q11.23. Cytogenet Cell Genet 82:238–246.
CrossRef Medline
Percipalle P, Fomproix N, Cavella´n E, Voit R, Reimer G, Kru¨ger T, Thyberg J,
Scheer U, Grummt I, Farrants AK (2006) The chromatin remodelling
complex WSTF-SNF2h interacts with nuclear myosin 1 and has a role in
RNA polymerase I transcription. EMBO Rep 7:525–530. Medline
Poot RA, Bozhenok L, van den Berg DL, Steffensen S, Ferreira F, GrimaldiM,
Gilbert N, Ferreira J, Varga-Weisz PD (2004) The Williams syndrome
transcription factor interacts with PCNA to target chromatin remodelling
by ISWI to replication foci. Nat Cell Biol 6:1236–1244. CrossRef Medline
Renthal W, Maze I, Krishnan V, Covington HE 3rd, Xiao G, Kumar A, Russo
SJ, GrahamA, Tsankova N, Kippin TE, Kerstetter KA, Neve RL, Haggarty
SJ, McKinsey TA, Bassel-Duby R, Olson EN, Nestler EJ (2007) Histone
deacetylase 5 epigenetically controls behavioral adaptations to chronic
emotional stimuli. Neuron 56:517–529. CrossRef Medline
Russo SJ, Nestler EJ (2013) The brain reward circuitry in mood disorders.
Nat Rev Neurosci 14:609–625. Medline
Sarshad A, Sadeghifar F, Louvet E, Mori R, Bo¨hm S, Al-Muzzaini B, Vinter-
mist A, Fomproix N, O¨stlund AK, Percipalle P (2013) Nuclear myosin
1c facilitates the chromatinmodifications required to activate rRNA gene
transcription and cell cycle progression. PLoS Genet 9:e1003397.
CrossRef Medline
Scobie KN, Damez-Werno D, Sun H, Shao N, Gancarz A, Panganiban CH,
Dias C, Koo J, Caiafa P, Kaufman L, Neve RL, Dietz DM, Shen L, Nestler
EJ (2014) Essential role of poly(ADP-ribosyl)ation in cocaine action.
Proc Natl Acad Sci U S A 111:2005–2010. CrossRef Medline
Shen L, ShaoNY, Liu X,Maze I, Feng J, Nestler EJ (2013) diffReps: detecting
differential chromatinmodification sites fromChIP-seq datawith biolog-
ical replicates. PLoS One 8:e65598. CrossRef Medline
Sun H, Kennedy PJ, Nestler EJ (2013) Epigenetics of the depressed brain:
role of histone acetylation and methylation. Neuropsychopharmacology
38:124–137. CrossRef Medline
Sun H, Damez-Werno DM, Scobie KN, Shao NY, Dias C, Rabkin J, Koo JW,
Korb E, Bagot RC, Ahn FH, Cahill ME, Labonte B, Mouzon E, Heller EA,
Cates H, Golden SA, Gleason K, Russo SJ, Andrews S, Neve R, et al.
(2015) ACF chromatin-remodeling complex mediates stress-induced
depressive-like behavior. Nat Med 21:1146–1153. CrossRef Medline
Takada I (2015) DGCR14 induces Il17a gene expression through the ROR-
gamma/BAZ1B/RSKS2 complex. Mol Cell Biol 35:344–355. CrossRef
Medline
Vintermist A, Bo¨hm S, Sadeghifar F, Louvet E, Manse´n A, Percipalle P, Ost-
lund Farrants AK (2011) The chromatin remodelling complex B-WICH
changes the chromatin structure and recruits histone acetyl-transferases
to active rRNA genes. PLoS One 6:e19184. CrossRef Medline
Vogel-Ciernia A, Matheos DP, Barrett RM, Kramar EA, Azzawi S, Chen Y,
MagnanCN, ZellerM, Sylvain A,Haettig J, Jia Y, TranA,Dang R, Post RJ,
Chabrier M, Babayan AH, Wu JI, Crabtree GR, Baldi P, Baram TZ, et al.
(2013) The neuron-specific chromatin regulatory subunit BAF53b is
necessary for synaptic plasticity and memory. Nat Neurosci 16:552–561.
CrossRef Medline
Watson CT, Disanto G, Sandve GK, Breden F, Giovannoni G, Ramagopalan
SV (2012) Age-associated hyper-methylated regions in the human brain
overlap with bivalent chromatin domains. PLoS One 7:e43840. CrossRef
Medline
Werner CT, Milovanovic M, Christian DT, Loweth JA, Wolf ME (2015)
Response of the ubiquitin-proteasome system to memory retrieval after
extended-access cocaine or saline self-administration.Neuropsychophar-
macology 40:3006–3014. CrossRef Medline
Whitehouse I, RandoOJ, Delrow J, TsukiyamaT (2007) Chromatin remod-
elling at promoters suppresses antisense transcription. Nature 450:1031–
1035. CrossRef Medline
Xiao A, Li H, Shechter D, Ahn SH, Fabrizio LA, Erdjument-Bromage H,
Ishibe-Murakami S,Wang B, Tempst P, Hofmann K, Patel DJ, Elledge SJ,
Allis CD (2009) WSTF regulates theH2A.XDNA damage response via a
novel tyrosine kinase activity. Nature 457:57–62. CrossRef Medline
Yen K, Vinayachandran V, Batta K, Koerber RT, Pugh BF (2012) Genome-
wide nucleosome specificity and directionality of chromatin remodelers.
Cell 149:1461–1473. CrossRef Medline
Yoshimura K, Kitagawa H, Fujiki R, Tanabe M, Takezawa S, Takada I,
Yamaoka I, Yonezawa M, Kondo T, Furutani Y, Yagi H, Yoshinaga S,
Masuda T, Fukuda T, Yamamoto Y, Ebihara K, Li DY, Matsuoka R,
Takeuchi JK,MatsumotoT, et al. (2014) Retraction for Yoshimura et al.,
Distinct function of 2 chromatin remodeling complexes that share a com-
mon subunit,Williams syndrome transcription factor (WSTF). ProcNatl
Acad Sci U S A 111:2398. Medline
Sun et al. • NAc BAZ1B Regulates Reward-Related Behaviors J. Neurosci., April 6, 2016 • 36(14):3954–3961 • 3961
